Transcription factors WT1 and p53 combined: a prognostic biomarker in ovarian cancer

被引：0
|
作者：
Julia H. Carter
James A. Deddens
Gretchen Mueller
Thomas G. Lewis
Mariah K. Dooley
Michelle C. Robillard
Molly Frydl
Lydia Duvall
Jackson O. Pemberton
Larry E. Douglass
机构：
[1] Wood Hudson Cancer Research Laboratory,Department of Mathematical Sciences
[2] University of Cincinnati,undefined
[3] St. Elizabeth Healthcare,undefined
来源：
British Journal of Cancer | 2018年 / 119卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：462 / 470
页数：8
相关论文
共 50 条
  • [41] 肾母细胞瘤组织WT1、P53基因缺失检测
    宋东奎
    王瑞
    潘周辉
    步星耀
    郑州大学学报(医学版), 2002, (03) : 305 - 308
  • [42] Immunohistochemical Expression of p53 and WT1 Is Retained Following Chemotherapy in High-Grade Serous Tubo-Ovarian Carcinoma (HGSC)
    Ganesan, Raji
    Singh, Naveena
    Casey, Laura
    Tam, Simone
    Farugi, Asma
    Prasad, Rajeev
    Boehm, Steffen
    Lockley, Michelle
    Jeyarajah, Arjun J.
    Gilks, Blake
    Koebel, Martin
    LABORATORY INVESTIGATION, 2017, 97 : 286A - 287A
  • [43] Immunohistochemical Expression of p53 and WT1 Is Retained Following Chemotherapy in High-Grade Serous Tubo-Ovarian Carcinoma (HGSC)
    Ganesan, Raji
    Singh, Naveena
    Casey, Laura
    Tam, Simone
    Faruqi, Asma
    Prasad, Rajeev
    Boehm, Steffen
    Lockley, Michelle
    Jeyarajah, Arjun J.
    Gilks, Blake
    Koebel, Martin
    MODERN PATHOLOGY, 2017, 30 : 286A - 287A
  • [44] Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic Nephropathy
    Abe, Hideharu
    Sakurai, Akiko
    Ono, Hiroyuki
    Hayashi, Sanae
    Yoshimoto, Sakiya
    Ochi, Arisa
    Ueda, Sayo
    Nishimura, Kenji
    Shibata, Eriko
    Tamaki, Masanori
    Kishi, Fumi
    Kishi, Seiji
    Murakami, Taichi
    Nagai, Kojiro
    Doi, Toshio
    JOURNAL OF MEDICAL INVESTIGATION, 2018, 65 (3-4): : 208 - 215
  • [45] Cytosolic p53 protein and serum p53 autoantibody evaluation in breast cancer. Comparison with prognostic factors
    Dalifard, I
    Daver, A
    Larra, F
    ANTICANCER RESEARCH, 1999, 19 (6B) : 5015 - 5022
  • [46] The modulator PICT1 of p53 as a gastric cancer biomarker
    Yoshinaga, Takuma
    Kawahara, Kouichi
    Nishimata, Hiroto
    Furukawa, Tatsuhiko
    Takei, Takayuki
    Yoshida, Masahiro
    CANCER SCIENCE, 2018, 109 : 722 - 722
  • [47] Prognostic impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer
    Gunakan, Emre
    Tohma, Yusuf Aytac
    Karakas, Latife Atasoy
    Akilli, Huseyin
    Haberal, Asuman Nihan
    Ayhan, Ali
    OBSTETRICS & GYNECOLOGY SCIENCE, 2020, 63 (04) : 464 - 469
  • [48] Role of p53 and Rb in ovarian cancer
    Corney, David C.
    Flesken-Nikitin, Andrea
    Choi, Jinhyang
    Nikitin, Alexander Yu.
    OVARIAN CANCER: STATE OF THE ART AND FUTURE DIRECTIONS IN TRANSLATIONAL RESEARCH, 2008, 622 : 99 - 117
  • [49] Expression of p53 in epithelial ovarian cancer
    Ozalp, S
    Yalcin, OT
    Minsin, TH
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2000, 71 (03) : 277 - 278
  • [50] The role of p53 alterations in ovarian cancer
    Kounelis, S
    Kanbour-Shakir, A
    Papadakis, H
    Theocharis, SE
    Bakker, A
    Swalsky, PA
    Finkelstein, SD
    LABORATORY INVESTIGATION, 1999, 79 (01) : 119A - 119A
12345